DataMeds AI, Inc. — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 78/100
What the filing says
DataMeds AI filed an 8-K on 2026-10-16 disclosing two critical items: (1) entry into a material definitive agreement (Item 1.01) with unspecified counterparty, terms, and dollar amount not detailed in the filing header; and (2) notice of delisting or failure to satisfy continued listing standards (Item 3.01), indicating the company no longer meets exchange requirements. An unregistered equity sale (Item 3.02) was also reported. Specific financial terms, counterparty names, and agreement details are not provided in the accessible filing excerpt.
Why this rating
Delisting notice is business-critical for any $27M public company—threatens market access, liquidity, and valuation. Material agreement details absent but context suggests survival-focused transaction.
Extracted items
- 1.01 material agreement
- 3.01 delisting notice
- 3.02
Price action (we called it negative)
before filing · preread $2.66 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.